Skip to main content
Market intelligence
PLSEHealthcare

Pulse Biosciences Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
May 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 11, 2026Paul A LavioletteChief Executive OfficerOpen Market Purchase15,000$19.69$295,350
May 11, 2026Robert W DugganCorporate insiderOpen Market Purchase660,233$19.69$12,999,988